Education
Elena De Falco
EDUCATION:
2006 PhD Immunology, Sapienza University of Rome
2003 Board Certification, University of Tuscia, Viterbo, Italy
2001 Master Degree (Biological Sciences) 110/110 cum laude, Sapienza University of Rome
2001 Post-graduate trainee, Department of General Surgery and Organ Transplantation “P. Stefanini”, Policlinico Umberto I°, Rome, Italy
1998-2001 Graduate student, Laboratory of Immunology, Istituto Superiore di Sanità, Rome, Italy
POSITIONS:
• Current Position from 30/10/2015: Associate Professor (MED46, 06/N1), Sapienza University of Rome, Faculty of Pharmacy and Medicine, Department of Medical Surgical-Sciences and Biotechnologies
• 30/12/2011-29/10/2015 Assistant Professor Sapienza University of Rome, Faculty of Pharmacy and Medicine, Department of Medical Surgical-Sciences and Biotechnologies
• 2008-2011 Senior Associate Professor/Healthcare Scientist, Gene Therapy Laboratory, Institute of Child Health (Great Ormond Street Hospital), University College of London, London, United Kingdom
• 2007-2008 Research Associate King’s College University, Cardiovascular Department, Denmark Hill, London, United Kingdom
• From 2012 to date Research Consultant (ad hoc) Ismeri srl, Roma
• 2009 Internship, The Lancet/Elsevier, London, United Kingdom
• 2003-2007 Assistant Professor (Co.Co.Co/Co.Co.Pro.), Laboratory of Vascular Pathology, Istituto Dermopatico dell’Immacolata IDI, Rome, Italy
• 2002-2003 Assistant Professor (Co.Co.Co), Centro Cardiologico Monzino, Milan, Italy
TEACHING ASSIGNMENT AT "Sapienza" University of Rome:
• Interdisciplinary Class II, MS program in Diagnostic Techniques (A);
• Physiology, MS program in Medical Radiology Techniques for Imaging and Radiotherapy (D);
• Cell, tissue and organ Bioengineering-technical biotechnologies in surgery, CLM Medical Biotechnologies
• Cell, tissue and organ Bioengineering-technical biotechnologies in surgery, CLM Medical Biotechnologies
EDITORIAL RESPONSIBILITIES:
• National Reviewer Board Subscription
• Peer Reviewer (ad hoc) for the following scientific Journals: PlosOne, Cytotechnology, Current Genomics, FASEBbio, Journal of Immunology Research, Recent Patents in Regenerative Medicine, Cell Transplantation, Stem cell international, Biomed Res International.
MAIN FUNDINGS:
• 2011: Treatment of corneal lesions using limbal stem cells (Co-Investigator). Prot. N. C26A11MP7J . Sapienza University. € 8000.
• 2012: Cell-based gene therapy in acute ischemia reperfusion injury: novel tool for regenerative medicine. Prot. N. C26A12FJPF (Principal Investigator). Sapienza University. € 6000.
• 2013: Setting up of a biosafety level 2 facility (P2) for genetic manipulation of pro- and eukaryotic cells for biomedical and translational applications. Prot. N. C26G13WLNT (Co-Investigator). Sapienza University. € 53000.
• 2013: Influence of the in vitro microenvironment cardiosphere-derived in the cell plasticity of human adipose tissue-derived mesenchymal stem cells. Prot. N. C26A13SC2R. (Principal Investigator). Sapienza University. € 5000.
• 2014: Epigenetic modifications and microRNA analyis of cardiac-like differentiated human mesenchymal stem cells. Prot. C26A1429M2. (Principal Investigator). Sapienza University. € 5000.
• 2014: Microscopia avanzata con sistema video confocale ad alta risoluzione per la comprensione di meccanismi fisiopatologici complessi. Prot. C26G14PSY (Co-Investigator). Sapienza University. € 70000.
• 2014: Sistemi per la formazione pratica‐simulata in ambito biomedico (Creazione di un Laboratorio didattico di colture cellulari‐medicina rigenerativa e di un Laboratorio didattico‐diagnostico di imaging per piccoli animali). Principal Investigator for the action 4.1. Fondazione Roma. € 215.000.
• 2015: Cardiac regeneration: Characterization, optimization and evaluation of force developed by engineered tissue obtained from spontaneous or scaffold based 3D culture of paediatric human adipose tissue-derived mesenchymal stem cells. Finalizzata Sanità. Project Code CO-2013-02359690. (Co-Investigator). Ministry of Health. € 409383.
• 2015: An advanced combined approach: nanocomposite biomaterials and Mesenchymal stem cells as tools to reduce cardiac fibrosis. Prot. C26A1578EJ (Co-Investigator). € 10000.
2006 PhD Immunology, Sapienza University of Rome
2003 Board Certification, University of Tuscia, Viterbo, Italy
2001 Master Degree (Biological Sciences) 110/110 cum laude, Sapienza University of Rome
2001 Post-graduate trainee, Department of General Surgery and Organ Transplantation “P. Stefanini”, Policlinico Umberto I°, Rome, Italy
1998-2001 Graduate student, Laboratory of Immunology, Istituto Superiore di Sanità, Rome, Italy
POSITIONS:
• Current Position from 30/10/2015: Associate Professor (MED46, 06/N1), Sapienza University of Rome, Faculty of Pharmacy and Medicine, Department of Medical Surgical-Sciences and Biotechnologies
• 30/12/2011-29/10/2015 Assistant Professor Sapienza University of Rome, Faculty of Pharmacy and Medicine, Department of Medical Surgical-Sciences and Biotechnologies
• 2008-2011 Senior Associate Professor/Healthcare Scientist, Gene Therapy Laboratory, Institute of Child Health (Great Ormond Street Hospital), University College of London, London, United Kingdom
• 2007-2008 Research Associate King’s College University, Cardiovascular Department, Denmark Hill, London, United Kingdom
• From 2012 to date Research Consultant (ad hoc) Ismeri srl, Roma
• 2009 Internship, The Lancet/Elsevier, London, United Kingdom
• 2003-2007 Assistant Professor (Co.Co.Co/Co.Co.Pro.), Laboratory of Vascular Pathology, Istituto Dermopatico dell’Immacolata IDI, Rome, Italy
• 2002-2003 Assistant Professor (Co.Co.Co), Centro Cardiologico Monzino, Milan, Italy
TEACHING ASSIGNMENT AT "Sapienza" University of Rome:
• Interdisciplinary Class II, MS program in Diagnostic Techniques (A);
• Physiology, MS program in Medical Radiology Techniques for Imaging and Radiotherapy (D);
• Cell, tissue and organ Bioengineering-technical biotechnologies in surgery, CLM Medical Biotechnologies
• Cell, tissue and organ Bioengineering-technical biotechnologies in surgery, CLM Medical Biotechnologies
EDITORIAL RESPONSIBILITIES:
• National Reviewer Board Subscription
• Peer Reviewer (ad hoc) for the following scientific Journals: PlosOne, Cytotechnology, Current Genomics, FASEBbio, Journal of Immunology Research, Recent Patents in Regenerative Medicine, Cell Transplantation, Stem cell international, Biomed Res International.
MAIN FUNDINGS:
• 2011: Treatment of corneal lesions using limbal stem cells (Co-Investigator). Prot. N. C26A11MP7J . Sapienza University. € 8000.
• 2012: Cell-based gene therapy in acute ischemia reperfusion injury: novel tool for regenerative medicine. Prot. N. C26A12FJPF (Principal Investigator). Sapienza University. € 6000.
• 2013: Setting up of a biosafety level 2 facility (P2) for genetic manipulation of pro- and eukaryotic cells for biomedical and translational applications. Prot. N. C26G13WLNT (Co-Investigator). Sapienza University. € 53000.
• 2013: Influence of the in vitro microenvironment cardiosphere-derived in the cell plasticity of human adipose tissue-derived mesenchymal stem cells. Prot. N. C26A13SC2R. (Principal Investigator). Sapienza University. € 5000.
• 2014: Epigenetic modifications and microRNA analyis of cardiac-like differentiated human mesenchymal stem cells. Prot. C26A1429M2. (Principal Investigator). Sapienza University. € 5000.
• 2014: Microscopia avanzata con sistema video confocale ad alta risoluzione per la comprensione di meccanismi fisiopatologici complessi. Prot. C26G14PSY (Co-Investigator). Sapienza University. € 70000.
• 2014: Sistemi per la formazione pratica‐simulata in ambito biomedico (Creazione di un Laboratorio didattico di colture cellulari‐medicina rigenerativa e di un Laboratorio didattico‐diagnostico di imaging per piccoli animali). Principal Investigator for the action 4.1. Fondazione Roma. € 215.000.
• 2015: Cardiac regeneration: Characterization, optimization and evaluation of force developed by engineered tissue obtained from spontaneous or scaffold based 3D culture of paediatric human adipose tissue-derived mesenchymal stem cells. Finalizzata Sanità. Project Code CO-2013-02359690. (Co-Investigator). Ministry of Health. € 409383.
• 2015: An advanced combined approach: nanocomposite biomaterials and Mesenchymal stem cells as tools to reduce cardiac fibrosis. Prot. C26A1578EJ (Co-Investigator). € 10000.